Kevin Young Chao, MD
Dermatology · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Golden State Dermatology Associates, Inc. · 118 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Chao’s office at (916) 772-1585 to ask if they take your plan before you enroll.
California Medical Board record
Licence A165309 · Current
Licensed to practise in California · since 2019 · expires 2027-09-30 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 106 | More than 93% of doctors who do this |
| Removal of skin cancer | 629 | More than 70% of doctors who do this |
| Removal of skin lesions | 16 | More than 63% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Drugs they prescribed that Part D paid
$3,225
Pharmacies billed $3,225 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (19 of 153) in 2024. A higher opioid share than 9 in 10 peers; the typical dermatology clinician is at 0%.
153 generic and 0 brand-name prescriptions · $3,225 in drug cost · 24 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluorouracil | 13 | $475 | $37 |
| Clobetasol Propionate | 14 | $372 | $27 |
| Doxycycline Monohydrate | 18 | $322 | $18 |
| Ketoconazole | 18 | $320 | $18 |
| Fluocinolone Acetonide | 11 | $302 | $27 |
See all 7 drugs
| Fluorouracil | 13 | $475 | $37 |
| Clobetasol Propionate | 14 | $372 | $27 |
| Doxycycline Monohydrate | 18 | $322 | $18 |
| Ketoconazole | 18 | $320 | $18 |
| Fluocinolone Acetonide | 11 | $302 | $27 |
| Triamcinolone Acetonide | 13 | $206 | $16 |
| Hydrocodone-Acetaminophen | 16 | $151 | $9 |
Year by year
| 2024 | 153 | 76 | 12% (19) | 0% | $3,225 |
| 2023 | 42 | 28 | None | 0% | $1,175 |
| 2020 | 17 | None | 0% (0) | 0% | $414 |
| 2019 | 111 | 43 | 0% (0) | 21% | $7,553 |
| 2018 | 110 | 31 | 0% (0) | 22% | $4,509 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Clopidogrel | 14 | $318 | $23 |
2018: 1 drug
| Clopidogrel | 15 | $414 | $28 |
Money from drug and device companies
$121 in 2025
| 2025 | 2 | 2 | None | $121 |
| 2024 | 1 | 2 | None | $113 |
| 2023 | 3 | 4 | None | $359 |
| 2022 | 8 | 12 | None | $1,273 |
| 2021 | 2 | 3 | None | $242 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $95 | 1 payment
|
| Sun Pharmaceutical Industries | Odomzo | $25 | 1 payment
|
See all 2 published payments
| Genzyme | Meals · 2025-12-10 | Dupixent | $95 |
| Sun Pharmaceutical Industries | Meals · 2025-12-09 | Odomzo | $25 |
See earlier years (2024, 2023, 2022, 2021)
2024: $113
| E.R. Squibb & Sons L.L.C. | Sotyktu | $113 | 2 payments
|
2023: $359
| Galderma Laboratories L.P. | None | $144 | 2 payments
|
| Dermavant Sciences | Vtama | $133 | 1 payment
|
| AbbVie | Rinvoq | $83 | 1 payment
|
2022: $1,273
| Journey Medical | Qbrexza | $262 | 2 payments
|
| Galderma Laboratories L.P. | Oracea | $245 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $226 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | None | $124 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $122 | 1 payment
|
| Abbvie | Botox | $105 | 1 payment
|
| Helsinn Therapeutics (U.S.) | Valchlor | $99 | 1 payment
|
| Incyte | Opzelura | $90 | 1 payment
|
2021: $242
| Amgen | Otezla | $137 | 2 payments
|
| AbbVie | Skyrizi | $105 | 1 payment
|
Professional record
- NPI
- 1780187500
- Licence
- CA A165309California A165309: Current · expires 2027-09-30
- Trained
- University of California, Geffen School of Medicine, 2018
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ND0101X (207ND0101X); Federal specialty code 207N00000X (207N00000X); Federal specialty code 207NS0135X (207NS0135X)
- Mailing address
- 9269 Sierra College Blvd, Roseville, CA, 95661
- NPI first listed
- 2018-03-18
- NPI last updated
- 2025-08-22
- NPI record certified
- 2025-08-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 8899 University Center Ln Ste 350, San Diego, CA, 92122 · 276 International Cir, San Jose, CA, 95119
This office lists an electronic records connection.